Buprenorphine via Telehealth-Closing the Gap for Pregnant and Postpartum Women With Opioid Use Disorder.

Landis RK, Terplan M, Andraka-Christou B, Cantor J

Open source

DOI
10.1001/jamainternmed.2026.4106
Published
2026 Sep 21
Container
JAMA internal medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamainternmed.2026.4106,
  title = {Buprenorphine via Telehealth-Closing the Gap for Pregnant and Postpartum Women With Opioid Use Disorder.},
  author = {Landis RK and Terplan M and Andraka-Christou B and Cantor J},
  year = {2026},
  journal = {JAMA internal medicine},
  doi = {10.1001/jamainternmed.2026.4106},
  url = {https://doi.org/10.1001/jamainternmed.2026.4106}
}

RIS

TY  - JOUR
TI  - Buprenorphine via Telehealth-Closing the Gap for Pregnant and Postpartum Women With Opioid Use Disorder.
AU  - Landis RK
AU  - Terplan M
AU  - Andraka-Christou B
AU  - Cantor J
PY  - 2026
JO  - JAMA internal medicine
DO  - 10.1001/jamainternmed.2026.4106
UR  - https://doi.org/10.1001/jamainternmed.2026.4106
ER  - 

APA

RK, L., M, T., B, A., & J, C. (2026). Buprenorphine via Telehealth-Closing the Gap for Pregnant and Postpartum Women With Opioid Use Disorder.. JAMA internal medicine. https://doi.org/10.1001/jamainternmed.2026.4106

Source records